STOCKHOLDERS’ EQUITY |
12 Months Ended |
|---|---|
Dec. 31, 2021 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY | NOTE 3. STOCKHOLDERS’ EQUITY
General
On September 21, 2020, the Company issued shares of common stock related to a convertible note conversion.
On September 23, 2020, the Company issued shares of common stock related to a convertible note conversion.
On September 24, 2020, the Company issued shares of common stock related to a convertible note conversion.
On September 25, 2020, the Company issued shares of common stock related to a convertible note conversion.
On September 29, 2020, the Company issued shares of common stock related to a convertible note conversion.
On October 6, 2020, the Company issued shares of common stock related to a convertible note conversion.
On October 16, 2020, the Company issued shares of common stock related to a convertible note conversion.
On November 2, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 3, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 8, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 10, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 10, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 14, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 15, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 17, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 21, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 15, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 24, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 24, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 28, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 29, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 30, 2020, the Company issued shares of common stock related to a convertible note conversion.
On December 31, 2020, the Company issued shares of common stock related to a convertible note conversion.
During the year ended December 31, 2020, the Company issued shares of common stock to service providers. The shares were valued at the closing market price on their respective grant dates for a total value of $24,915.
In January 2021, the Company issued a total of shares of common stock related to a convertible note conversions.
In February 2021, the Company issued a total of shares of common stock related to a convertible note conversions.
In March 2021, the Company issued a total of shares of common stock related to a convertible note conversions.
In April 2021, the Company issued a total of shares of common stock related to convertible notes.
In May 2021, the Company issued a total of shares of common stock related to convertible notes.
In June 2021, the Company issued a total of shares of common stock related to convertible notes.
In July 2021, the Company issued a total of shares of common stock related to convertible notes.
In August 2021, the Company issued a total of shares of common stock related to convertible notes.
In September 2021, the Company issued a total of shares of common stock related to convertible notes.
In December 2021, the Company issued a total of shares of common stock related to convertible notes.
During the year ended December 31, 2021, The Company issued 330,000,000 warrants to purchase common stock to investors in connection with the issuance of convertible notes payable. The warrants have a weighted average remaining term of years and a weighted average exercise price of $ per share.
Total warrants outstanding and exercisable as of December 31, 2021 and December 31, 2020 were 330,000,000 and zero, respectively.
|